Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Clinical trial NCT04956640 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04956640
Sponsor: Eli Lilly and Company
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Endometrial Neoplasms Ovarian Neoplasms Pancreatic Neoplasms Biliary Tract Neoplasms

Start date: 2021-07-19
Primary completion: 2027-04-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.